Press Releases

Date Title and Summary
Toggle Summary Accuray to Participate in the Cowen 41st Annual Health Care Conference
Company to take part in Fireside Chat Tuesday, March 2nd, 2021 at 11:50 am PT / 2:50 pm ET SUNNYVALE, Calif. , Feb. 23, 2021 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) today announced its participation in the Cowen Annual Health Care Conference .
Toggle Summary Accuray Appoints Healthcare Executive and Physician Byron C. Scott to Board of Directors
SUNNYVALE, Calif. , Feb. 19, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Byron C. Scott , M.D., MBA to the company's Board of Directors, effective as of February 12, 2021 . Dr. Scott brings significant experience as a physician executive with
Toggle Summary Accuray to Participate in BTIG's Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
Company to take part in Fireside Chat Thursday, February 18th, 2021 at 12:30 pm PT / 3:30 pm ET SUNNYVALE, Calif. , Feb. 5, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced its participation in BTIG's Virtual MedTech, Digital Health , Life Science and Diagnostic Tools
Toggle Summary Accuray Reports Second Quarter Fiscal 2021 Financial Results
SUNNYVALE, Calif. , Jan. 27, 2021 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the second quarter of fiscal 2021 ended December 31, 2020 .     Second Quarter Fiscal 2021 Summary Net revenue of $97.5 million including $21.3 million of system revenue
Toggle Summary Seven-year Data Shows Accuray TomoTherapy® System Provides Excellent Long-Term Control of Low-Risk Breast Cancer
Advanced, 10-Day Radiation Treatment Regimen Enables Patients to Get Back to Their Life, Faster SUNNYVALE, Calif. , Jan. 19, 2021 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that data from a prospective, phase II trial of 338 women with low-risk breast cancer showed 98.8
Toggle Summary Accuray to Report Second Quarter Fiscal 2021 Financial Results on January 27, 2021
SUNNYVALE, Calif. , Jan. 8, 2021 /PRNewswire/ --  Accuray Incorporated  (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2021, ended December 31, 2020, after the market close on Wednesday January 27, 2021. Management will host a conference call to review the
Toggle Summary Accuray To Participate at J.P. Morgan's 39th Annual Healthcare Conference
Company to present on Thursday, January 14, 2021 at 11 am PT / 2 pm ET SUNNYVALE, Calif. , Jan. 6, 2021 /PRNewswire/ --  Accuray Incorporated (Nasdaq: ARAY) today announced its participation in the 39 th J.P. Morgan Annual Healthcare Conference. Josh Levine , President and CEO, is scheduled to
Toggle Summary Accuray Receives 510(k) FDA Clearance for ClearRT™ Helical kVCT Imaging for the Radixact® Treatment Delivery System
New Option will Provide an Efficient, Versatile and Cost-Effective Approach for Obtaining Exceptional Quality Images SUNNYVALE, Calif. , Jan. 5, 2021 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that the company has received 510(k) clearance from the U.S.
Toggle Summary Accuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules
SUNNYVALE, Calif. , Dec. 3, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Stock Market Rules, equity inducement awards to Jim Dennison , the company's new Senior Vice President, Quality & Regulatory Affairs.  As a material inducement to Mr.
Toggle Summary Accuray and DHL Supply Chain establish global service logistics platform to support delivery of advanced cancer treatment technology
SUNNYVALE , Calif. and WESTERVILLE, Ohio , Nov. 18, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) and DHL Supply Chain announced today they have entered into a global service parts logistics partnership that will further strengthen the Accuray aftermarket supply chain and expand the

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.